Restricted access

Research article

First published online September, 2003

Immunization of Patients with Malignant Melanoma with Autologous CD34 + Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial